Skip to main content

Month: April 2025

Euronet Worldwide Reports First Quarter 2025 Financial Results – Highlighted by 18% Operating Income Growth

Record first quarter results – revenue, operating income and adjusted EBITDA Operating margin expansion of 80 basis points Continued expansion of its leading cross-border payments networkLEAWOOD, Kan., April 23, 2025 (GLOBE NEWSWIRE) — Euronet Worldwide, Inc. (“Euronet” or the “Company”) (NASDAQ: EEFT), a leading global financial technology solutions and payments provider, reports first quarter 2025 financial results. Euronet reports the following consolidated results for the first quarter 2025 compared with the same period of 2024:Revenues of $915.5 million, a 7% increase from $857.0 million (9% increase on a constant currency1 basis). Operating income of $75.2 million, an 18% increase from $64.0 million (22% increase on a constant currency basis). Adjusted operating income2 of $75.2 million, an 18% increase from $63.6...

Continue reading

Christina Lake Cannabis Announces Financing

VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) the Company is pleased to provide details regarding a proposed non-brokered private placement. The Company announces that it intends to complete a non-brokered private placement with gross proceeds of up to $2,500,000 (the “Offering”). The Company will be issuing units (“Units“) at a price of $0.05 per Unit, with each Unit consisting of one common share in the capital of the Company (the “Shares” and each a “Share“) and one half of one common share purchase warrant (each whole warrant a “Warrant“), exercisable for a term of 60 months at a price of $0.065 per Share. The Offering may include debt settlements...

Continue reading

Rogers Communications Announces Voting Results from Annual General Meeting of Shareholders

TORONTO, April 23, 2025 (GLOBE NEWSWIRE) — Rogers Communications Inc. (TSX: RCI.A and RCI.B) (NYSE: RCI) (the “Company”), in accordance with Toronto Stock Exchange requirements, announced the voting results from its Annual General Meeting of Shareholders held earlier today. Shareholders voted for all items of business put forth at today’s meeting, those being the election of the director nominees and the appointment of KPMG LLP as the Company’s auditors. A total of 108,564,494 Class A Voting shares, representing approximately 97.67% of the Company’s issued and outstanding Class A Voting shares, were voted in connection with the election of directors.Director Nominee Result % of Shares Voted For % of Shares Voted WithholdMichael J. Cooper Elected 99.970% 0.030%Trevor English Elected 99.965% 0.035%Ivan Fecan Elected 99.984% 0.016%Robert...

Continue reading

HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 24, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED including savolitinib, fruquintinib and surufatinib, which will be presented at the upcoming American Association of Cancer Research (AACR) Annual Meeting 2025, taking place on April 25-30, 2025 in Chicago, Illinois. Details of the presentations are as follows:Abstract title Presenter / Lead author Presentation detailsSPONSORED STUDIESTargeting KEAP1/NRF2 signaling sensitizes KRAS-driven NSCLC to KRAS inhibitors Xianwen Yang, HUTCHMED, Shanghai, China 4450Poster Session (PO.ET03.04)Tuesday, April 29, 2025SAVANNAH: Clearance of plasma EGFRm in patients with EGFRm MET-overexpressed...

Continue reading

Jade Power Announces Director Appointment

TORONTO, April 23, 2025 (GLOBE NEWSWIRE) — Jade Power Trust (“Jade Power” or the “Trust”) (NEX:JPWR.H) is pleased to announce the appointment of an independent director, Bruce McCannel, to the Board of Directors of Jade Power Administrator Inc., effective immediately. Bruce is currently a corporate consultant primarily focused on government and stakeholder engagement and communications strategies. Holding a Master of Public Administration degree, Bruce worked in budget development for the Saskatchewan Ministry of Finance, was an Executive Director for the Ministry of Parks, Culture and Sport, and was on the board of directors for the Canadian Parks Council. When he was the head coach of the University of Regina Cougars Track and Field program, Bruce was a member of the board of directors for Saskatchewan Athletics and the Excel...

Continue reading

Mueller Water Products Announces Dates for Second Quarter 2025 Earnings Release and Conference Call

ATLANTA, April 23, 2025 (GLOBE NEWSWIRE) — Mueller Water Products, Inc. (NYSE: MWA) plans to release financial results for its second quarter ended March 31, 2025, after U.S. markets close on Monday, May 5, 2025. On Tuesday, May 6, 2025, at 10:00 a.m. ET, the Company will hold a conference call to discuss earnings and business results. Interested parties are invited to listen via webcast available on the Investor Relations section of the Company’s website www.muellerwaterproducts.com. An archive of the webcast will be available for approximately 90 days following the call. About Mueller Water Products, Inc. Mueller Water Products, Inc. is a leading manufacturer and marketer of products and solutions used in the transmission, distribution and measurement of water in North America.  Our broad portfolio includes engineered valves,...

Continue reading

Ascentage Pharma To Present Data from Two Clinical Studies at 2025 ASCO Annual Meeting, Including Oral Presentation on Its Key Assets Lisaftoclax and Alrizomadlin

ROCKVILLE, Md. and SUZHOU, China, April 23, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for hematological malignancies, today announced that results from two clinical studies of the Bcl-2 selective inhibitor lisaftoclax (APG-2575) and the MDM2-p53 inhibitor alrizomadlin (APG-115), two key drug candidates in the company’s apoptosis-targeted pipeline, have been selected for presentations at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. These presentations will include an oral report featuring updated results from a Phase Ib/II study of a lisaftoclax combination regimen in patients with myeloid malignancies. The ASCO Annual Meeting showcases...

Continue reading

Imperial Reports Production Update for 2025 First Quarter and Petition Filed Relating to the Mount Polley Tailings Storage Facility Raise

VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) — Imperial Metals Corporation (“Imperial”) (TSX:III) reports copper and gold production for the first quarter 2025 from Mount Polley and Red Chris mines. Imperial’s production was 15.8 million pounds copper and 17,120 ounces gold, with 8.9 million pounds copper and 10,621 ounces gold coming from Mount Polley and 6.9 million pounds copper and 6,499 ounces gold from its 30% share of Red Chris mine production. Both copper and gold production were up compared with the first quarter of 2024, with copper production up 28% and gold production up 33%. Mount Polley metal production (100%) for the first quarter of 2025 was 8.904 million pounds copper and 10,621 ounces gold, compared to 7.355 million pounds copper and 10,009 ounces gold produced during the first quarter of 2024.Mount...

Continue reading

Precision Drilling Announces 2025 First Quarter Unaudited Financial Results

CALGARY, Alberta, April 23, 2025 (GLOBE NEWSWIRE) — This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For a full disclosure of the forward-looking information and statements and the risks to which they are subject, see the “Cautionary Statement Regarding Forward-Looking Information and Statements” later in this news release. This news release contains references to certain Financial Measures and Ratios, including Adjusted EBITDA (earnings before income taxes, gain on investments and other assets, finance charges, foreign exchange, gain on asset disposals and depreciation and amortization), Funds Provided by (Used in) Operations, Net Capital Spending, Working Capital and Total Long-term Financial Liabilities. These terms do not have standardized meanings prescribed...

Continue reading

Northfield Bancorp, Inc. Announces First Quarter 2025 Results

NOTABLE ITEMS FOR THE QUARTER INCLUDE:DILUTED EARNINGS PER SHARE WERE $0.19 FOR THE CURRENT QUARTER COMPARED TO $0.27 FOR THE TRAILING QUARTER, AND $0.15 FOR THE FIRST QUARTER OF 2024.Fourth Quarter 2024 earnings included a gain of $3.4 million, or $0.06 per share, on the sale and consolidation of a branch in December 2024.NET INTEREST MARGIN INCREASED TO 2.38% FOR THE CURRENT QUARTER AS COMPARED TO 2.18% FOR THE TRAILING QUARTER AND 2.03% FOR THE FIRST QUARTER OF 2024, REFLECTING LOWER FUNDING COSTS AND HIGHER YIELDS ON INTEREST-EARNING ASSETS. DEPOSITS (EXCLUDING BROKERED) INCREASED $133.6 MILLION, OR 13.8% ANNUALIZED, FROM DECEMBER 31, 2024. COST OF DEPOSITS AT MARCH 31, 2025 WAS 1.94% AS COMPARED TO 1.95% AT DECEMBER 31, 2024. LOANS DECLINED BY $30.7 MILLION, OR 3.0% ANNUALIZED, FROM DECEMBER 31, 2024, PRIMARILY DUE TO A DECREASE...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.